CLPTM1L is a GPI-anchoring pathway component targeted by HCMV

Inbal Kol*, Ahmed Rishiq, Mevaseret Cohen, Shira Kahlon, Ophir Pick, Liat Dassa, Natan Stein, Yotam Bar-On, Dana G. Wolf, Einat Seidel, Ofer Mandelboim*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'CLPTM1L is a GPI-anchoring pathway component targeted by HCMV'. Together they form a unique fingerprint.

Keyphrases

Neuroscience

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science